Equities Marking a New High -- Research on JD.com, NRG Energy, Merrimack Pharma and Arris Group

LONDON, May 28, 2014 /PRNewswire/ --

The U.S. markets on Tuesday, May 27, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,675.50, up 0.42% and the NASDAQ Composite closed at 4,237.07, up 1.22%. The S&P 500 finished the session 0.60% higher at 1,911.91. During the trading session, nine out of ten sectors finished on a higher note. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include JD.com Inc. (NASDAQ: JD), NRG Energy Inc. (NYSE: NRG), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) and Arris Group Inc. (NASDAQ: ARRS). Free technical research on JD, NRG, MACK and ARRS can be downloaded upon signing up at:

http://www.investor-edge.com/3094-register

JD.com Inc.'s stock ended the day at $22.97, up 14.28%, hitting a new 52-week high of $22.98. The stock vacillated between $20.25 and $22.98 and a total of 15.32 million shares were traded during the session. Over the last three trading sessions, JD.com Inc.'s shares have rallied 20.89%. Sign up today to read free research on JD at:

http://www.investor-edge.com/3094-JD-28May2014.pdf

On Tuesday, NRG Energy Inc.'s stock oscillated between $34.75 and $35.33, hitting a new 52-week high of $35.33. Shares in the company surged 4.72% higher to end the session at $35.31. The company's stock reported a trading volume of 6.44 million shares, much above its three months average volume of 3.76 million shares. Shares of the company traded at a PE ratio of 14.13. NRG Energy Inc.'s shares have gained 5.00% in the previous three trading sessions, 6.48% in the last one month, and 22.95% on YTD basis. The S&P 500 Utilities Sector Index registered a gain of 0.82% during the session, with the index gaining 4.58% in the previous three months. NRG Energy Inc.'s stock is trading above its 50-day and 200-day moving averages of $32.49 and $28.92, respectively. Moreover, shares of the company have an RSI of 55.99. Sign up today to read free research on NRG at:

http://www.investor-edge.com/3094-NRG-28May2014.pdf

Shares in Merrimack Pharmaceuticals Inc. gained 6.38% on Tuesday, finishing the day at $8.00, hitting a new 52-week high of $8.06. The stock recorded a trading volume of 2.69 million shares, above its three months average volume of 2.12 million shares. The stock oscillated between $7.57 and $8.06 during the trading session. Over the last three trading sessions and past one month, Merrimack Pharmaceuticals Inc.'s shares have rallied 16.62% and 78.97%, respectively. Furthermore, the stock has surged 50.07% since the start of this year. The S&P 500 Health Care Sector Index recorded a gain of 0.56% during the session, with the index advancing 3.21% in the last one month. The stock is trading above its 50-day and 200-day moving averages. Merrimack Pharmaceuticals Inc.'s 50-day moving average of $5.63 is above its 200-day moving average of $4.61. Additionally, the stock has an RSI of 70.49. Sign up today to read free research on MACK at:

http://www.investor-edge.com/3094-MACK-28May2014.pdf

On Tuesday, ARRIS Group Inc.'s stock gained 2.16%, closing the day at $31.70, after hitting a new 52-week high of $31.99. The stock recorded a trading volume of 2.96 million shares, above its three month average volume of 1.89 million shares. Shares of the company traded at a PE ratio of 49.77. ARRIS Group Inc.'s shares have surged 6.88% in the previous three trading sessions, 23.06% in the last one month, and 30.24% on YTD basis. The S&P 500 Information Technology Sector Index advanced 0.99% during the session, with the index gaining 5.14% in the last one month. ARRIS Group Inc.'s stock is trading above its 50-day and 200-day moving averages of $27.70 and $22.68, respectively. Furthermore, shares of the company have an RSI of 69.64. Sign up today to read free research on ARRS at:

http://www.investor-edge.com/3094-ARRS-28May2014.pdf

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED